Cryptic determinants and promiscuous sequences on human acetylcholine receptor: HLA-dependent dichotomy in T-cell function

Human Immunology

Volumn 63, Issue 4, 2002, Pages 237-247

  Raju, Raghavanpillai ^a,b   Marietta, Eric ^a   Vinasco, Javier ^a   Conti Fine, Bianca M ^b   Infante, Anthony J ^c   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Antigen presentation; Autoimmunity; Cytokines; Myasthenia gravis; Transgenic knockout

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; CYTOKINE; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; HLA SYSTEM; IMMUNE RESPONSE; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CYTOKINES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-DQ ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; PEPTIDE FRAGMENTS; RECEPTORS, CHOLINERGIC; T-LYMPHOCYTES;

EID: 0036229420     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00362-2     Document Type: Article

References (38)

1. Myasthenia gravis
2. Autoimmune T cells in myasthenia gravis: Heterogeneity and potential for specific immunotargeting
3. CD4+ T epitope repertoire on the human acetylcholine receptor alpha subunit in sever myasthenia gravis: A study with synthetic peptides
4. Autoimmune T cell recognition of human acetylcholine receptor: The sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit
5. Analysis of helper T cell function by AChR-reactive cell lines of defined supernatent subunit specificity
6. Interaction and activation of antigen-specific T and B cells
7. A new look at MHC and autoimmune disease
8. The role of histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis
9. Association of HLA-B8, Drw3, and anti-acetylcholine receptor antibodies in myasthenia gravis
10. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: A population-based survey in the province of Ferrara, northern Italy
11. Different HLA-DQ are positively and negatively associated in Swedish patients with maysthenia gravis
12. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis
13. HLA-DQ8 transgenic mice are highly susceptible to collagen induced arthritis: A novel model for human polyarthritis
14. Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice
15. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis
16. Gene organization of DC and DX subregions of the human major histocompatibility complex
17. Mice lacking MHC class II molecules
18. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis
19. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: A study using HLA DQ8 and DQ6 transgenic mice
20. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice
21. HLA-DQ6 and HLA-DQ8 transgenic mice respond to ragweed allergens and recognize a distinct set of epitopes on short and giant ragweed group 5 allergens
22. HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens. Identification of antigenic epitopes
23. Immune response of HLA-DQ8 transgenic mice to peptides from the hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis
24. Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis
25. A very high level of crossreactivity is an essential feature of the T cell receptor
26. Biosynthetic and synthetic AChR sequences to study T cells in myasthenia gravis
27. Myasthenia gravis: Recognition of a human autoantigen at the molecular level
28. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spred and suppress murine myasthenia gravis
29. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: Amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide
30. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms
31. Altered peptide ligand modulation of experimental allergic encephalomyelitis: Immune responses within the CNS
32. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology
33. Major histocompatibility (MHC) control of CD4 cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype
34. Major histocompatibility complex regulation of cytokine production
35. MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo
36. The density of the class II MHC T cell receptor ligand influences IFN-g/IL-4 ratios in immune responses in vivo
37. High-density presentation of an immunodominant minimal peptide on B cells is MHC-linked to Th1-like immunity
38. In vitro cytokine production by HLA-B8, DR3 positive subjects